In epithelial ovarian carcinoma 8, clear cell renal cell carcinoma 9, glioma 10, gastric cancer 11, and pancreatic cancer 12, RUNX1 has been linked to tumor progression. Here, RUNX1 is linked to central nervous system cancer.